Literature DB >> 29779081

Activity of decitabine in pericardial myeloid sarcoma.

Dorothea Evers1, Brigitte M A M Bär1, Martin Gotthardt2, Walter J F M van der Velden3.   

Abstract

Entities:  

Keywords:  Acute myeloid leukemia; Decitabine; Hypomethylating agent; Myeloid sarcoma; Pericardium

Mesh：

Substances：

Year:  2018        PMID： 29779081     DOI： 10.1007/s12185-018-2470-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  2 in total

1.  Evidence for a role of decitabine in the treatment of myeloid sarcoma.

Authors:  Max Gornicec; Albert Wölfler; Susanne Stanzel; Heinz Sill; Armin Zebisch
Journal:  Ann Hematol       Date:  2016-11-06       Impact factor: 3.673

Review 2.  Cardiac Myeloid Sarcoma: Review of Literature.

Authors:  Archana Gautam; Ghazal Kooshk Jalali; Kamal Kant Sahu; Prateek Deo; Sikander Ailawadhi
Journal:  J Clin Diagn Res       Date:  2017-03-01
  2 in total
  5 in total

1.  Long-Lasting Remission in De Novo Breast Myeloid Sarcoma Treated with Decitabine and Radiotherapy.

Authors:  Carla Minoia; Vincenza de Fazio; Giovanni Scognamillo; Anna Scattone; Nicola Maggialetti; Cristina Ferrari; Attilio Guarini
Journal:  Diagnostics (Basel)       Date:  2019-07-27

2.  Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency.

Authors:  Jinhuan Wang; Zhaoyi Miao; Yanan Jiang; Ping Zou; Weiming Li; Xiaoqiong Tang; Yangyang Lv; Donghui Xing; Shi Chen; Fengchun Yang; Mingjiang Xu; Zeng Cao; Haitao Wang; Zhigang Zhao
Journal:  Oncol Lett       Date:  2020-03-27       Impact factor: 2.967

3.  Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine.

Authors:  Kazuya Sato; Nodoka Tsukada; Junki Inamura; Shigetsuna Komatsu; Keisuke Sato; Masayo Yamamoto; Motohiro Shindo; Kentaro Moriichi; Yusuke Mizukami; Mikihiro Fujiya; Yoshihiro Torimoto; Toshikatsu Okumura
Journal:  Case Rep Hematol       Date:  2021-04-21

4.  Serial Analysis and Comparison of Mutation Profiles in Decitabine-treated Myeloid Sarcoma and Subsequent Acute Myeloid Leukemia Using Next-Generation Sequencing.

Authors:  Hee Sue Park; Seung Myoung Son; Jihyun Kwon
Journal:  Ann Lab Med       Date:  2022-09-01       Impact factor: 4.941

5.  Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma.

Authors:  Haiqiu Zhao; Zhenkun Dong; Dingming Wan; Weijie Cao; Haizhou Xing; Zhenzhen Liu; Jixin Fan; Haiqiong Wang; Runqing Lu; Yinyin Zhang; Qianqian Cheng; Zhongxing Jiang; Fei He; Xinsheng Xie; Rong Guo
Journal:  Sci Rep       Date:  2022-04-26       Impact factor: 4.996
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.